Professor Suradej Hongeng is an internationally acclaimed pediatric hematologist-oncologist with over 20 years of experience and American Board certification. He has treated over 2,000 pediatric patients and successfully performed more than 800 bone marrow transplants, with a 90% success rate in thalassemia cases. His pioneering research in CAR T-Cell therapy and gene-editing treatments for thalassemia, in collaboration with Harvard Medical School, has advanced global standards in pediatric oncology and regenerative medicine. He is also a Professor at Ramathibodi Hospital, Mahidol University.

Educational Qualification:

• 1984 – M.D., Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand
• 1987 – Bachelor’s Degree, Doctor of Medicine, Mahidol University
• 1991 – Diploma of the Thai Board of Pediatrics
• 1993 – Diploma of the American Board of Pediatrics
• 1996 – Diploma of the American Board of Pediatric Hematology and Oncology
• 2011 – Academic Appointment: Professor, Ramathibodi Hospital, Mahidol University

Professional Experience:

• Professor – Ramathibodi Hospital, Mahidol University
• Senior Consultant – Pediatric Hematology and Oncology, Samitivej Srinakarin Hospital
• Over 2,000 pediatric patients treated and 800+ bone marrow transplants performed

Awards & Achievements:

• Pioneered gene-editing therapy for thalassemia in collaboration with Harvard Medical School
• Developed CAR T-Cell therapy with 80% remission rates for pediatric cancers
• Achieved 90% success in thalassemia treatment through advanced transplant techniques

Fellowship:

• Fellowship in Hematology and Oncology – St. Jude Children’s Research Hospital, USA - 1993

Publications:

• Extensive research publications on pediatric oncology, stem cell transplantation, and adoptive immunotherapy